Arrhythmias & electrophysiology
Rationale and design of a registry-based randomized controlled study of personalized biomarker-based risk score-guided stroke prevention treatment in atrial fibrillation
Study context
- Population
- Consenting patients with atrial fibrillation (AF) registered in the Swedish national quality register for AF (AURICULA AF)recruited
- Participants
- 3,933 patients
- Planned comparison
- ABC-AF risk score-guided treatment recommendations vs standard care
- Primary endpoint
- Composite of:
- Stroke
- Death
Methodological detailsnational, multicentre, prospective, parallel-group, open-label, 1:1 randomisation, Enrollment commenced October 25, 2018, terminated May 12, 2023
- National
- Multicentre
- Prospective
- Parallel-group
- Open-label
- 1:1 randomisation
- Enrollment commenced October 25, 2018, terminated May 12, 2023
No results yet. This paper sets out the design of a trial; its results are to come.
Original publication
Rationale and design of a registry-based randomized controlled study of personalized biomarker-based risk score-guided stroke prevention treatment in atrial fibrillation. Am Heart J. Published 23 June 2025. doi:10.
Summarised from the published abstract; every number is checked against it